Colon Cancer with Complete Pathological Response to Only 1 Cycle of Capecitabine: Treatment Modification in the Perspective of COVID-19 Pandemic
International Journal of Medical and Pharmaceutical Case Reports,
Incidence of colorectal cancer has surged in the past few decades, currently it accounts for approximately 10% cancer related mortality. Upfront curative surgery is the main stay of treatment for localized disease followed by adjuvant chemotherapy for high-risk disease; however, neo adjuvant chemoradiation followed by surgery and chemotherapy is a standard treatment for rectal cancer. Here, we present a case of a young male aged 33 years with eight months’ history of per rectal bleeding, associated with fever and weight loss who was later diagnosed as sigmoid colon adenocarcinoma. The patient managed to have only one cycle of neoadjuvant capecitabine, as his definitive surgery was delayed due to the rife in pandemic situation of Covid-19. Notably, follow up laparoscopic LAR specimen showed no residual disease, nevertheless, there was an eosinophilic abscess with a giant cell reaction and Ova of Ascaris lumbricoides, which seemingly contributed in achieving pathological complete response with minimal therapy.
- Colon Cancer
- Covid-19 Pandemic
- Complete Pathological Response
How to Cite
Shang FM, Liu HL: Fusobacterium nucleatum and colorectal cancer: A review. World J Gastrointest Oncol. 2018’10:71-81.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012:1-441.
Blanca E. Callejas, Diana Martínez-Saucedo, Luis I: Terrazas; Parasites as negative regulators of cancer. Biosci Rep 31 October. 2018;38:20180935.
Haller DG, Catalano PJ, Macdonald JS, et al.: Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089. J Clin Oncol. 2005;23:8671-8678.
V, Glimelius B, Haustermans K, et al.: ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol. 2012;23:2479-516.
Foxtrot Collaborative Group: Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol. 2012; 13:1152-1160.
Liu F, Yang L, Wu Y, et al.: CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase II trial. Chin J Cancer Res. 2016; 28:589-597.
Deo SVS, Kumar S, Kumar N, et al.: Guiding Principles for Cancer Surgery during the COVID-19 Pandemic [published online ahead of print, 2020 May 6]. Indian J Surg Oncol. 2020;1:8.
Bethony J, Brooker S, Albonico M, et al.: Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006;6:1521-32.
Jourdan PM, Lamberton PHL, Fenwick A, Addiss DG: Soil-transmitted helminth infections. Lancet. 2018;391:252-265.
Catalano C, Aron J, Bansal R, Leytin A.: Colorectal Cancer Associated with Strongyloides stercoralis Colitis. ACG Case Rep J. 2017;30:1.
Pastille E, Frede A, McSorley HJ, et al.: Intestinal helminth infection drives carcinogenesis in colitis-associated colon cancer. PLoS Pathog. 2017;13: 1006649.
Finkelman FD, Shea-Donohue T, Goldhill J, et al. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu Rev Immunol. 1997;15:505-533.
Pompei R, Lampis G, Ingianni A, et al.: Allergy and tumour outcome after primary cancer therapy. Int Arch Allergy Immunol. 2004;133:174-8.
Abstract View: 40 times
PDF Download: 10 times